Data di Pubblicazione:
2008
Abstract:
We wish to commemorate Paul Ehrlich, on the centennial of his being awarded the Nobel Prize in Physiology or Medicine in 1908. His studies are now considered as milestones in immunology: the morphology of leucocytes, his side-chain theory when he defined the cellular receptor for first time, and his clarification of the difference between serum therapy and chemotherapy. Ehrlich also invented the first chemotherapeutic drug: compound 606 or Salvarsan. We have used some original documents from the Royal Society of London, where Ehrlich was a Fellow, and from Leipzig University, where he took a degree in Medicine.
Tipologia CRIS:
01.01 Articolo in rivista
Keywords:
Nobel prize; immunology; chemotherapy; immunity
Elenco autori:
Quattrone, Aldo; Piro, Anna; Lagonia, Paolo; Tagarelli, Giuseppe; Tagarelli, Antonio
Link alla scheda completa:
Pubblicato in: